zolpidem has been researched along with oxytocin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bundzikova, J; Kiss, A; Mikkelsen, JD; Pirnik, Z; Søderman, A | 1 |
1 review(s) available for zolpidem and oxytocin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for zolpidem and oxytocin
| Article | Year |
|---|---|
Zolpidem, a selective GABA(A) receptor alpha1 subunit agonist, induces comparable Fos expression in oxytocinergic neurons of the hypothalamic paraventricular and accessory but not supraoptic nuclei in the rat.
Topics: Animals; Biomarkers; GABA Agonists; GABA-A Receptor Agonists; Immunohistochemistry; Injections, Intraperitoneal; Male; Neurons; Oxytocin; Paraventricular Hypothalamic Nucleus; Proto-Oncogene Proteins c-fos; Pyridines; Rats; Rats, Wistar; Receptors, GABA-A; Supraoptic Nucleus; Zolpidem | 2006 |